High-pressure oxygen: Israeli researchers develop ‘very effective treatment’ for fibromyalgia

By
June 16, 2015 17:46
1 minute read.

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Tel Aviv University researchers have found that treatment in a hyperbaric (high-pressure) oxygen chamber improves the condition of women suffering from fibryomyalgia - a syndrome characterized by chronic widespread pain and a heightened and painful response to pressure.

Between two percent and 4% of the populations in Western countries have the chronic condition, 90% of whose sufferers are women. Until now, there has been no effective treatment for it.

The TAU-led team, which also included scientists from Assaf Harofeh Medical Center, Ben-Gurion University, Tel Aviv Sourasky Medical Center and Rice University in Houston, Texas, has just been published in the open access journal ITAL PLoS One END ITAL (Public Library of Science One). The brain mapping technique used was carried out with technology developed by the late TAU physicist Prof. Eshel Ben-Jacob.

The team developed an innovative and effective oxygen treatment that they say “improved significantly” the condition of 70% of the women who participated in the clinical study and could alleviate the suffering of millions of (mostly) women around the world.

The exact cause of fibromyalgia - which is related to chronic fatigue syndrome (which also causes much suffering among millions of women and men in the world) - is unknown, but experts say it involves genetic, psychological, neurobiological and environmental factors. Pain - the main symptom - appears to result from neurochemical imbalances including activation of inflammatory pathways in the brain, which results in abnormalities in pain processing.

Related Content

Breaking news
July 18, 2018
Nicaraguan police surround, attack anti-government stronghold

By REUTERS